These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1697 related items for PubMed ID: 16786000

  • 1. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM, Rao JS.
    Oncogene; 2006 Aug 03; 25(33):4559-72. PubMed ID: 16786000
    [Abstract] [Full Text] [Related]

  • 2. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
    Henrique R, Jerónimo C, Hoque MO, Carvalho AL, Oliveira J, Teixeira MR, Lopes C, Sidransky D.
    DNA Cell Biol; 2005 Apr 03; 24(4):264-9. PubMed ID: 15812243
    [Abstract] [Full Text] [Related]

  • 3. Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.
    Lodygin D, Diebold J, Hermeking H.
    Oncogene; 2004 Dec 02; 23(56):9034-41. PubMed ID: 15489902
    [Abstract] [Full Text] [Related]

  • 4. 14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence.
    Schultz J, Ibrahim SM, Vera J, Kunz M.
    Mol Cancer; 2009 Jul 30; 8():53. PubMed ID: 19642975
    [Abstract] [Full Text] [Related]

  • 5. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS.
    Prostaglandins Other Lipid Mediat; 2007 Jan 30; 82(1-4):185-97. PubMed ID: 17164146
    [Abstract] [Full Text] [Related]

  • 6. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
    Chen Y, Gao W, Luo J, Tian R, Sun H, Zou S.
    Oncol Rep; 2011 Feb 30; 25(2):443-51. PubMed ID: 21165562
    [Abstract] [Full Text] [Related]

  • 7. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.
    Singal R, van Wert J, Bashambu M.
    Cancer Res; 2001 Jun 15; 61(12):4820-6. PubMed ID: 11406558
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation.
    Mhawech P, Benz A, Cerato C, Greloz V, Assaly M, Desmond JC, Koeffler HP, Lodygin D, Hermeking H, Herrmann F, Schwaller J.
    Mod Pathol; 2005 Mar 15; 18(3):340-8. PubMed ID: 15257317
    [Abstract] [Full Text] [Related]

  • 9. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
    Stirzaker C, Song JZ, Ng W, Du Q, Armstrong NJ, Locke WJ, Statham AL, French H, Pidsley R, Valdes-Mora F, Zotenko E, Clark SJ.
    Oncogene; 2017 Mar 15; 36(10):1328-1338. PubMed ID: 27593931
    [Abstract] [Full Text] [Related]

  • 10. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
    Lee J, Lee MS, Jeoung DI, Kim YM, Lee H.
    Prostate; 2017 Mar 15; 77(4):350-360. PubMed ID: 27813113
    [Abstract] [Full Text] [Related]

  • 11. 14-3-3sigma is down-regulated in human prostate cancer.
    Urano T, Takahashi S, Suzuki T, Fujimura T, Fujita M, Kumagai J, Horie-Inoue K, Sasano H, Kitamura T, Ouchi Y, Inoue S.
    Biochem Biophys Res Commun; 2004 Jul 02; 319(3):795-800. PubMed ID: 15184053
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic regulation of the cell type-specific gene 14-3-3sigma.
    Oshiro MM, Futscher BW, Lisberg A, Wozniak RJ, Klimecki WT, Domann FE, Cress AE.
    Neoplasia; 2005 Sep 02; 7(9):799-808. PubMed ID: 16229802
    [Abstract] [Full Text] [Related]

  • 13. Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice.
    Yu S, Khor TO, Cheung KL, Li W, Wu TY, Huang Y, Foster BA, Kan YW, Kong AN.
    PLoS One; 2010 Jan 05; 5(1):e8579. PubMed ID: 20062804
    [Abstract] [Full Text] [Related]

  • 14. p21WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation.
    Bott SR, Arya M, Kirby RS, Williamson M.
    Prostate Cancer Prostatic Dis; 2005 Jan 05; 8(4):321-6. PubMed ID: 16276353
    [Abstract] [Full Text] [Related]

  • 15. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
    Müller I, Wischnewski F, Pantel K, Schwarzenbach H.
    BMC Cancer; 2010 Jun 17; 10():297. PubMed ID: 20565761
    [Abstract] [Full Text] [Related]

  • 16. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC, Yu Y.
    Cancer Res; 2003 Jul 15; 63(14):4174-80. PubMed ID: 12874023
    [Abstract] [Full Text] [Related]

  • 17. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C, Song JZ, Davidson B, Clark SJ.
    Cancer Res; 2004 Jun 01; 64(11):3871-7. PubMed ID: 15172996
    [Abstract] [Full Text] [Related]

  • 18. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y.
    Oncogene; 2002 Jul 18; 21(31):4822-9. PubMed ID: 12101420
    [Abstract] [Full Text] [Related]

  • 19. Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers.
    Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Imai K.
    Cancer Res; 2000 Aug 15; 60(16):4353-7. PubMed ID: 10969776
    [Abstract] [Full Text] [Related]

  • 20. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.
    Jarrard DF, Kinoshita H, Shi Y, Sandefur C, Hoff D, Meisner LF, Chang C, Herman JG, Isaacs WB, Nassif N.
    Cancer Res; 1998 Dec 01; 58(23):5310-4. PubMed ID: 9850055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 85.